How much funding has Cartiva raised?

Cartiva has raised $8.5M in total funding, most recently a Series D round.

Who are Cartiva's investors?

Cartiva's investors include Wright Medical Group N.V., New Enterprise Associates.

Where is Cartiva headquartered?

Cartiva is headquartered in Atlanta, Georgia, United States.

What industry is Cartiva in?

Cartiva operates in Medical Devices, Orthopedics.

Cartiva

Acquired

Atlanta, United States · Founded 2013 · $8.5M raised

Medical Devices

Orthopedics

Headquarters: Atlanta, Georgia
Employees: 11–50
Founded: 2013
Business Model: B2B

Website: cartiva.net
Total Funding: $8.5M
Last Round: $8.5M Series DMay 2015
Rounds: 1

About

Cartiva developed the Synthetic Cartilage Implant (SCI), the first and only FDA-approved synthetic cartilage device for treating osteoarthritis of the first metatarsophalangeal (big toe) joint. The SCI is composed of a biocompatible polyvinyl alcohol hydrogel polymer with mechanical properties mimicking natural articular cartilage, implantable in approximately 35 minutes. The company was acquired by Wright Medical Group N.V. in October 2018 for $435 million, and subsequently became part of Stryker following Stryker's acquisition of Wright Medical in 2020.

Summary

Cartiva is a Medical Devices company based in Atlanta, United States, founded in 2013. It has raised $8.5M in total across 1 round, most recently a $8.5M Series D round in May 2015. Investors include Wright Medical Group N.V. and New Enterprise Associates.